Login Register Cart 0
Generic placeholder image

The Natural Products Journal

Editor-in-Chief

ISSN (Print): 2210-3155
ISSN (Online): 2210-3163

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Mini-Review Article

A Comprehensive Mini Review on the Natural Product Bacopa monnieri for the Management of Alzheimer’s Disease

Author(s): Naman Jain, Omkar Tambekar, Tanvi Goel, Subhash Laxmanrao Bodhankar and Deepali Amol Bansode*

Volume 14, Issue 2, 2024

Published on: 01 August, 2023

Article ID: e260623218280 Pages: 12

DOI: 10.2174/2210315514666230626161007

Price: $65

Abstract

Central nervous system disorders are expected to profoundly impact the global healthcare needs of the human community in this era. Senile decay of neurons is (Alzheimers Disease) AD. The hallmark of the pathophysiology of AD disease has two pivotal features: extracellular beta-amyloid deposition and intracellular tau hyperphosphorylation. New medicine-based psychoactive treatments have met with modest effectiveness due to the multifactorial nature of these diseases. As a result, there is an increasing need for new products that can address various receptors and enhance behavioral abilities independently or in tandem with traditional medications. Herbal products focused on conventional expertise have recently been widely popular in developed and developing countries. Ayurveda is a medical science that deals with the treatment of diseases using naturally occurring plant products. Ayurveda claims to have a large number of neuroprotective herbs. This review discusses the pharmacological effects and therapeutic properties of In vivo, In vitro, In silico and human clinical trials of (Bacopa monnieri) BM against AD.

[1]
Sharma, S.; Rathi, N.; Kamal, B.; Pundir, D.; Kaur, B.; Arya, S. Conservation of biodiversity of highly important medicinal plants of India through tissue culture technology- A review. Agric. Biol. J. N. Am., 2010, 1(5), 827-833.
[http://dx.doi.org/10.5251/abjna.2010.1.5.827.833]
[2]
Roy, A. A Review on Pharmaceutically Important Medicinal Plant. Bacopa Monnieri. J. Nat. Prod. Plant Resour., 2017, 2017, 7.
[3]
Dubey, T.; Chinnathambi, S. Brahmi (Bacopa monnieri): An ayurvedic herb against the Alzheimer’s disease. Arch. Biochem. Biophys., 2019, 676, 108153.
[http://dx.doi.org/10.1016/j.abb.2019.108153] [PMID: 31622587]
[4]
Murthy, P.B.S.; Raju, V.R.; Ramakrisana, T.; Chakravarthy, M.S.; Kumar, K.V.; Kannababu, S.; Subbaraju, G.V. Estimation of twelve bacopa saponins in Bacopa monnieri extracts and formulations by high-performance liquid chromatography. Chem. Pharm. Bull., 2006, 54(6), 907-911.
[http://dx.doi.org/10.1248/cpb.54.907] [PMID: 16755069]
[5]
Deepak, M.; Sangli, G.K.; Arun, P.C.; Amit, A. Quantitative determination of the major saponin mixture bacoside A inBacopa monnieri by HPLC. Phytochem. Anal., 2005, 16(1), 24-29.
[http://dx.doi.org/10.1002/pca.805] [PMID: 15688952]
[6]
Deepak, M.; Amit, A. ‘Bacoside B’ — the need remains for establishing identity. Fitoterapia, 2013, 87, 7-10.
[http://dx.doi.org/10.1016/j.fitote.2013.03.011] [PMID: 23506783]
[7]
Mathur, A.; Verma, S.K.; Purohit, R.; Singh, S.K.; Mathur, D.; Prasad, G.; Dua, V.K. Pharmacological investigation of bacopa monnieri on the basis of antioxidant, antimicrobial and anti-inflammatory properties. J. Chem. Pharm. Res., 2010, 2, 191-198.
[8]
Morgan, A.; Stevens, J. Does Bacopa monnieri improve memory performance in older persons? Results of a randomized, placebo-controlled, double-blind trial. J. Altern. Complement. Med., 2010, 16(7), 753-759.
[http://dx.doi.org/10.1089/acm.2009.0342] [PMID: 20590480]
[9]
Rauf, K.; Subhan, F.; Ali, G.; Ayaz, M. Effect of acute and sub chronic use of bacopa monnieri on dopamine and serotonin turnover in mice whole brain Khalid Rauf1. Afr. J. Pharm. Pharmacol., 2012, 6, 2767-2774.
[10]
Watthanasuebsin, P.; Sittiprapaporn, P. Effect of Brahmi Extract on Human Brainwaves. Proceedings of the 2017 International Conference on Digital Arts, Media and Technology (ICDAMT), IEEEChiang Mai, 2017, pp. 364-368.
[http://dx.doi.org/10.1109/ICDAMT.2017.7904993]
[11]
Hota, S.K.; Barhwal, K.; Baitharu, I.; Prasad, D.; Singh, S.B.; Ilavazhagan, G. Bacopa monniera leaf extract ameliorates hypobaric hypoxia induced spatial memory impairment. Neurobiol. Dis., 2009, 34(1), 23-39.
[http://dx.doi.org/10.1016/j.nbd.2008.12.006] [PMID: 19154788]
[12]
Thomas, R.B.; Joy, S.; Ajayan, M.S.; Paulose, C.S. Neuroprotective potential of Bacopa monnieri and Bacoside A against dopamine receptor dysfunction in the cerebral cortex of neonatal hypoglycaemic rats. Cell. Mol. Neurobiol., 2013, 33(8), 1065-1074.
[http://dx.doi.org/10.1007/s10571-013-9973-0] [PMID: 23975094]
[13]
Saraf, M.K.; Prabhakar, S.; Khanduja, K.L.; Anand, A. 2011, 2011. Bacopa Monniera Attenuates Scopolamine-Induced Impairment of Spatial Memory in Mice. Altern. Med., 2011, 2011, 236186.
[14]
Goyal, K.; Konar, A.; Kumar, A.; Koul, V. Bacosides encapsulated in lactoferrin conjugated PEG-PLA-PCL-OH based polymersomes act as epigenetic modulator in chemically induced amnesia. Neurochem. Res., 2020, 45(4), 796-808.
[http://dx.doi.org/10.1007/s11064-020-02953-z] [PMID: 31960226]
[15]
Prabhakar, S.; Saraf, M.K.; Pandhi, P.; Anand, A. Bacopa monniera exerts antiamnesic effect on diazepam-induced anterograde amnesia in mice. Psychopharmacology, 2008, 200(1), 27-37.
[http://dx.doi.org/10.1007/s00213-007-1049-8] [PMID: 18193203]
[16]
Saraf, M.K.; Prabhakar, S.; Anand, A. Neuroprotective effect of Bacopa monniera on ischemia induced brain injury. Pharmacol. Biochem. Behav., 2010, 97(2), 192-197.
[http://dx.doi.org/10.1016/j.pbb.2010.07.017] [PMID: 20678517]
[17]
Mishra, A.; Mishra, A.K.; Jha, S. Effect of traditional medicine brahmi vati and bacoside A-rich fraction of Bacopa monnieri on acute pentylenetetrzole-induced seizures, amphetamine-induced model of schizophrenia, and scopolamine-induced memory loss in laboratory animals. Epilepsy Behav., 2018, 80, 144-151.
[http://dx.doi.org/10.1016/j.yebeh.2017.12.040] [PMID: 29414544]
[18]
Pandey, S.P.; Singh, H.K.; Prasad, S. Alterations in hippocampal oxidative stress, expression of AMPA Receptor GluR2 Subunit and Associated spatial memory loss by Bacopa monnieri Extract (CDRI-08) in streptozotocin-induced Diabetes Mellitus Type 2 mice. PLoS One, 2015, 10(7), e0131862.
[http://dx.doi.org/10.1371/journal.pone.0131862] [PMID: 26161865]
[19]
Dethe, S.; Deepak, M.; Agarwal, A. Elucidation of molecular mechanism(s) of cognition enhancing activity of Bacomind ®: A standardized extract of bacopa monnieri. Pharmacogn. Mag., 2016, 12(47)(Suppl. 4), 482.
[http://dx.doi.org/10.4103/0973-1296.191464] [PMID: 27761079]
[20]
Suganthy, N.; Pandian, S.K.; Devi, K.P. Cholinesterase inhibitors from plants: Possible treatment strategy for neurological disorders-a review. Int J Biomed Pharm Sci, 2009, 3, 87-103.
[21]
Yadav, M.; Parle, M.; Sharma, N.; Ghimire, K.; Khare, N. Role of bioactive phytoconstituents from several traditional herbs as natural neuroprotective agents; Inven; Rapid Planta. Act, 2016, p. 33.
[22]
Tichauer, J.E.; Flores, B.; Soler, B.; Eugenín-von Bernhardi, L.; Ramírez, G.; von Bernhardi, R. Age-dependent changes on TGFβ1 Smad3 pathway modify the pattern of microglial cell activation. Brain Behav. Immun., 2014, 37, 187-196.
[http://dx.doi.org/10.1016/j.bbi.2013.12.018] [PMID: 24380849]
[23]
Le, X.T.; Nguyet Pham, H.T.; Van Nguyen, T.; Minh Nguyen, K.; Tanaka, K.; Fujiwara, H.; Matsumoto, K. Protective effects of bacopa monnieri on ischemia-induced cognitive deficits in mice: The possible contribution of bacopaside I and underlying mechanism. J. Ethnopharmacol., 2015, 164, 37-45.
[http://dx.doi.org/10.1016/j.jep.2015.01.041] [PMID: 25660331]
[24]
Russo, A.; Izzo, A.A.; Borrelli, F.; Renis, M.; Vanella, A. Free radical scavenging capacity and protective effect ofBacopa monniera L. on DNA damage. Phytother. Res., 2003, 17(8), 870-875.
[http://dx.doi.org/10.1002/ptr.1061] [PMID: 13680815]
[25]
Apetz, N.; Munch, G.; Govindaraghavan, S.; Gyengesi, E. Natural compounds and plant extracts as therapeutics against chronic inflammation in Alzheimer’s Disease – a translational perspective. CNS Neurol. Disord. Drug Targets, 2014, 13(7), 1175-1191.
[http://dx.doi.org/10.2174/1871527313666140917110635] [PMID: 25230232]
[26]
Chauhan, N.B.; Mehla, J. Ameliorative effects of nutraceuticals in neurological disorders. Bioact. nutraceuticals Diet. Suppl. Neurol. brain Dis., 2015, 2015, 245-260.
[27]
Sivaraman, D.; Anbu, N.; Kabilan, N.; Kumar, M.P.; Shanmugapriya, P.; Christian, G.J. Review on current treatment strategy in Alzheimer’s Disease and role of herbs in treating neurological disorders. Int J Trans Res Ind Med, 2019, 1, 33-43.
[28]
Angelopoulos, T.; Scordilis, D.M.; Tsagkaris, C. Cognitive Impairment and Rehabilitation in Alzheimer’s Disease.Biological, Diagnostic and Therapeutic Advances in Alzheimer’s Disease; Springer: Heidelberg, 2019, pp. 1-30.
[http://dx.doi.org/10.1007/978-981-13-9636-6_1]
[29]
Uabundit, N.; Wattanathorn, J.; Mucimapura, S.; Ingkaninan, K. Cognitive enhancement and neuroprotective effects of Bacopa monnieri in Alzheimer’s disease model. J. Ethnopharmacol., 2010, 127(1), 26-31.
[http://dx.doi.org/10.1016/j.jep.2009.09.056] [PMID: 19808086]
[30]
Leonard, J. Production of Bacoside A-A Potent Herbal Drug for Alzheimer in Callus Cultures of Bacopa Monnieri (L.); Pennell, 2016.
[31]
Jamal, Q.M.S.; Siddiqui, M.U.; Alharbi, A.H.; Albejaidi, F.; Akhtar, S.; Alzohairy, M.A.; Kamal, M.A.; Kesari, K.K. A computational study of natural compounds from Bacopa monnieri in the Treatment of Alzheimer’s Disease. Curr. Pharm. Des., 2020, 26(7), 790-800.
[http://dx.doi.org/10.2174/1381612826666200102142257] [PMID: 31894743]
[32]
Banerjee, S.; Anand, U.; Ghosh, S.; Ray, D.; Ray, P.; Nandy, S.; Deshmukh, G.D.; Tripathi, V.; Dey, A. Bacosides fromBACOPA MONNIERI extract: An overview of the effects on neurological disorders. Phytother. Res., 2021, 35(10), 5668-5679.
[http://dx.doi.org/10.1002/ptr.7203] [PMID: 34254371]
[33]
Choudhury, F.K.; Rivero, R.M.; Blumwald, E.; Mittler, R. Reactive oxygen species, abiotic stress and stress combination. Plant J., 2017, 90(5), 856-867.
[http://dx.doi.org/10.1111/tpj.13299] [PMID: 27801967]
[34]
Nemetchek, M.D.; Stierle, A.A.; Stierle, D.B.; Lurie, D.I. The Ayurvedic plant Bacopa monnieri inhibits inflammatory pathways in the brain. J. Ethnopharmacol., 2017, 197, 92-100.
[http://dx.doi.org/10.1016/j.jep.2016.07.073] [PMID: 27473605]
[35]
Banerjee, A.; Schepmann, D.; Köhler, J.; Würthwein, E.U.; Wünsch, B. Synthesis and SAR studies of chiral non-racemic dexoxadrol analogues as uncompetitive NMDA receptor antagonists. Bioorg. Med. Chem., 2010, 18(22), 7855-7867.
[http://dx.doi.org/10.1016/j.bmc.2010.09.047] [PMID: 20965735]
[36]
Chen, H.S.; Pellegrini, J.W.; Aggarwal, S.K.; Lei, S.Z.; Warach, S.; Jensen, F.E.; Lipton, S.A. Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: Therapeutic advantage against NMDA receptor-mediated neurotoxicity. J. Neurosci., 1992, 12(11), 4427-4436.
[http://dx.doi.org/10.1523/JNEUROSCI.12-11-04427.1992] [PMID: 1432103]
[37]
Zhu, C.; Liu, Y.; Hu, L.; Yang, M.; He, Z.G. Molecular mechanism of the synergistic activity of ethambutol and isoniazid against Mycobacterium tuberculosis. J. Biol. Chem., 2018, 293(43), 16741-16750.
[http://dx.doi.org/10.1074/jbc.RA118.002693] [PMID: 30185616]
[38]
Winblad, B.; Poritis, N. Memantine in severe dementia: Results of the9M-best study (benefit and efficacy in severly demented patients during treatment with memantine). Int. J. Geriatr. Psychiatry, 1999, 14(2), 135-146.
[http://dx.doi.org/10.1002/(SICI)1099-1166(199902)14:2<135:AID-GPS906>3.0.CO;2-0] [PMID: 10885864]
[39]
Reisberg, B.; Doody, R.; Stöffler, A.; Schmitt, F.; Ferris, S.; Möbius, H.J. Memantine in moderate-to-severe Alzheimer’s disease. N. Engl. J. Med., 2003, 348(14), 1333-1341.
[http://dx.doi.org/10.1056/NEJMoa013128] [PMID: 12672860]
[40]
Zhang, Y.; Li, P.; Feng, J.; Wu, M. Dysfunction of NMDA receptors in Alzheimer’s disease. Neurol. Sci., 2016, 37(7), 1039-1047.
[http://dx.doi.org/10.1007/s10072-016-2546-5] [PMID: 26971324]
[41]
Bhushan, I.; Kour, M.; Kour, G.; Gupta, S.; Sharma, S.; Yadav, A. Alzheimer’s disease: Causes & treatment – A review. Annals of Biotechnology, 2018, 1(1), 1002.
[http://dx.doi.org/10.33582/2637-4927/1002]
[42]
Herholz, K.; Ebmeier, K. Clinical amyloid imaging in Alzheimer’s disease. Lancet Neurol., 2011, 10(7), 667-670.
[http://dx.doi.org/10.1016/S1474-4422(11)70123-5] [PMID: 21683932]
[43]
Markowitsch, H.J.; Staniloiu, A. Amnesic disorders. Lancet, 2012, 380(9851), 1429-1440.
[http://dx.doi.org/10.1016/S0140-6736(11)61304-4] [PMID: 22503117]
[44]
Scoville, W.B.; Milner, B. Loss of recent memory after bilateral hippocampal lesions. J. Neurol. Neurosurg. Psychiatry, 1957, 20(1), 11-21.
[http://dx.doi.org/10.1136/jnnp.20.1.11] [PMID: 13406589]
[45]
Selkoe, D.J. Alzheimer’s disease: Genes, proteins, and therapy. Physiol. Rev., 2001, 81(2), 741-766.
[http://dx.doi.org/10.1152/physrev.2001.81.2.741] [PMID: 11274343]
[46]
Priller, C.; Bauer, T.; Mitteregger, G.; Krebs, B.; Kretzschmar, H.A.; Herms, J. Synapse formation and function is modulated by the amyloid precursor protein. J. Neurosci., 2006, 26(27), 7212-7221.
[http://dx.doi.org/10.1523/JNEUROSCI.1450-06.2006] [PMID: 16822978]
[47]
Chaudhari, K.S.; Tiwari, N.R.; Tiwari, R.R.; Sharma, R.S. Neurocognitive effect of nootropic drug Brahmi (Bacopa monnieri) in Alzheimer’s Disease. Ann. Neurosci., 2017, 24(2), 111-122.
[http://dx.doi.org/10.1159/000475900] [PMID: 28588366]
[48]
Balmik, A.A.; Chinnathambi, S. Multi-faceted role of melatonin in neuroprotection and amelioration of tau aggregates in Alzheimer’s Disease. J. Alzheimers Dis., 2018, 62(4), 1481-1493.
[http://dx.doi.org/10.3233/JAD-170900] [PMID: 29562506]
[49]
Vishnupriya, P.; Padma, V.V. A review on the antioxidant and therapeutic potential of Bacopa Monnieri. React Oxyg. Spec, 2017, 3, 111-120.
[50]
Goswami, S.; Kumar, N.; Thawani, V.; Tiwari, M.; Thawani, M. Effect of Bacopa Monnieri on cognitive functions in Alzheimer??? S disease patients. Int. J. Collab. Res. Intern. Med. Public Health, 2011, 3(4), 1-10.
[51]
Tembhre, M.; Ahirwar, S.; Gour, S.; Namdeo, A. Inhibitory potential of acephate and ethanol extract of Bacopa Monnieri on AChE in Rat cortex and hippocampus. Int. J. Biosci. Biochem. Bioinform., 2015, 5(1), 45-53.
[http://dx.doi.org/10.17706/ijbbb.2015.5.1.45-53]
[52]
Debnath, T.; Kim, D.; Lim, B. Natural products as a source of anti-inflammatory agents associated with inflammatory bowel disease. Molecules, 2013, 18(6), 7253-7270.
[http://dx.doi.org/10.3390/molecules18067253] [PMID: 23783459]
[53]
Anand, T.; Pandareesh, M.D.; Bhat, P.V.; Venkataramana, M. Anti-apoptotic mechanism of Bacoside rich extract against reactive nitrogen species induced activation of iNOS/Bax/caspase 3 mediated apoptosis in L132 cell line. Cytotechnology, 2014, 66(5), 823-838.
[http://dx.doi.org/10.1007/s10616-013-9634-7] [PMID: 24061554]
[54]
Kalyani, M.I.; Lingaraju, S.M.; Salimath, B.P. A pro-apoptotic 15-kDa protein from Bacopa monnieri activates caspase-3 and downregulates Bcl-2 gene expression in mouse mammary carcinoma cells. J. Nat. Med., 2013, 67(1), 123-136.
[http://dx.doi.org/10.1007/s11418-012-0661-z] [PMID: 22467255]
[55]
Sangeet, S.; Khan, A. In silico studies of neurocognitive and neuropharmacological effect of Bacopa Monnieri (L.). bioRxiv, 2021.
[http://dx.doi.org/10.1101/2021.01.20.427542]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy